Transform Early-Stage Innovations into Robust, Scalable, and Commercially Viable Manufacturing Processes
Cell therapy process development services that bridge discovery and cGMP manufacturing. Our services accelerate novel therapies from early ideas or small-scale research to validated, cost-efficient, and regulatory-compliant manufacturing processes for cell therapies.
CellSecure Bio specializes in the custom design of modular, off-the-shelf systems without the burden of high CDMO overhead and infrastructure costs. We optimize upstream (cell isolation, expansion, transduction) and downstream (harvest, formulation) steps to improve yield, purity, viability, and potency while controlling costs.
We differentiate ourselves from large CDMOs by moving away from all-in-one, expensive automated systems with limited real-time troubleshooting capabilities, to nibble off-the-shelf, less expensive closed and semi-closed systems.
Cell Therapy Process Development & Manufacturing Optimization
Our team consists of leaders in the field of cell therapy with deep knowledge in novel cell therapy development, manufacturing, and patient clinical care. We benefit from experts who have developed and brought cell therapies to patients while working for biopharma and academic point-of-care manufacturing environments.
It is a long established fact that a reader will be distracted by the readable content of a page when at layout The point of using Ipsum.
It is a long established fact that a reader will be distracted by the readable content of a page when at layout The point of using Ipsum.
End-to-end process development and technology transfer services that optimize closed-system workflows, reduce tech-transfer risk, and keep programs on time.
We specialize in cellular therapies, supporting the development of CAR-T cells, TIL cells, TCR-modified cells, CD34+ blood stem cells, and many other specialized cell therapy products.
Our experience includes working with PBMNC, cord blood, and healthy donor-derived blood cells to help accelerate research, process development, and clinical manufacturing readiness.
Achieve consistent product quality, reduce manufacturing risks, accelerate IND/CTA filings, and prepare for commercialization.
Lowering the cost of goods (COGS) is critical for the commercial success of any cellular therapy. Our cellular therapy product development services are specifically engineered to deliver substantial cost savings without compromising quality or regulatory compliance. Our team will assist in identifying a lower-cost, high-value manufacturing site for our clients.
Cell therapy product development involves complex manufacturing workflows, temperature-sensitive materials, strict regulatory requirements, and critical timelines. We identify operational, cryogenic, and process-related risks early in development to minimize disruptions that can lead to costly delays or product loss.
Reducing time spent in process development, validation, and scale-up directly shortens the path to regulatory submission and commercial launch, enabling earlier patient access and faster return on investment.
Partner with CellSecure Bio to develop a cost-effective, efficient, and regulatory-compliant manufacturing process tailored to customers’ needs.
Contact our Cell Therapy Development Experts Today.
